PLEXUS CORP

Plexus Corp. (NASDAQ: PLXS) operates as a global electronics manufacturing services provider serving customers in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial market sectors. The company maintains its headquarters at www.plexus.com and operates 26 active facilities spanning approximately 5.0 million square feet across the Americas, Asia-Pacific, and Europe, Middle East and Africa regions, employing over 20,000 team members worldwide.

The company provides integrated solutions throughout the product lifecycle, including design and development services through six global design centers, supply chain optimization, new product introduction support, manufacturing capabilities, and sustaining services such as repair and refurbishment. Plexus operates on both a turnkey basis, where the company procures and warehouses all required materials, and on a consignment basis where customers supply materials while Plexus provides labor and services. The company does not design or manufacture proprietary products but rather serves as a partner to market-leading and emerging companies globally.

In fiscal 2025, Plexus served approximately 190 customers with no single customer accounting for more than 10 percent of sales. The company's revenue distribution across market sectors reflects Healthcare/Life Sciences at 40 percent, Industrial at 43 percent, and Aerospace/Defense at 17 percent. The company's 10 largest customers represented 49.1 percent of net sales, indicating significant customer concentration.

Plexus maintains extensive regulatory certifications and capabilities across its facilities, including ISO 9001:2015 quality management system certification at all manufacturing and engineering facilities, FDA Quality Systems Regulation compliance for medical device assembly, aerospace standard AS9100 certifications, and various environmental and occupational health and safety certifications. The company's strategic focus emphasizes market focus, superior execution, passion meets purpose, and discipline by design, with a long-term financial goal of achieving 9-12 percent compounded annual revenue growth while earning a 15 percent return on invested capital.